Pancreatic Secretory Atrophy: Causes & Treatment
Pancreatic secretory atrophy refers to the decline of the secretory function of the pancreas. It can cause digestive disorders and nutrient deficiencies.
Things worth knowing about "Pancreatic Secretory Atrophy"
Pancreatic secretory atrophy refers to the decline of the secretory function of the pancreas. It can cause digestive disorders and nutrient deficiencies.
What Is Pancreatic Secretory Atrophy?
Pancreatic secretory atrophy describes the reduction or loss of secretory activity in the pancreas. The pancreas is a vital gland that produces digestive enzymes (exocrine function) as well as hormones such as insulin and glucagon (endocrine function). In pancreatic secretory atrophy, it is primarily the exocrine secretion that is affected -- meaning the production and release of digestive enzymes and bicarbonate into the small intestine is significantly reduced or absent. This leads to impaired digestion and can have serious health consequences.
Causes
Pancreatic secretory atrophy can result from several underlying conditions:
- Chronic pancreatitis: Ongoing inflammation of the pancreas progressively destroys glandular tissue, reducing secretory capacity.
- Cystic fibrosis: A genetic disorder in which thick mucus blocks the pancreatic ducts and damages glandular tissue.
- Pancreatic cancer: A tumor can displace or destroy the surrounding glandular tissue.
- Pancreatic resection: Surgical removal of part or all of the pancreas directly results in loss of secretion.
- Autoimmune pancreatitis: An immune-mediated inflammation that leads to tissue destruction.
- Age-related changes: Physiological decline in pancreatic secretion can occur in older adults.
- Malnutrition: Severe protein or nutrient deficiency can impair the synthetic capacity of the pancreas.
Symptoms
Since pancreatic enzymes are essential for breaking down fats, proteins, and carbohydrates, pancreatic secretory atrophy leads to characteristic complaints:
- Steatorrhea: Fatty stools -- greasy, bulky, and foul-smelling stools due to incomplete fat digestion.
- Weight loss and general weakness caused by malabsorption.
- Bloating, abdominal pain, and a feeling of fullness after meals.
- Nutritional deficiencies, particularly of fat-soluble vitamins (A, D, E, K), vitamin B12, and other nutrients.
- In advanced cases: Diabetes mellitus, if the endocrine portion of the pancreas is also affected.
Diagnosis
The diagnosis of pancreatic secretory atrophy is established through a combination of clinical evaluation, laboratory tests, and imaging:
- Stool analysis: Measurement of fecal elastase-1 as an indirect test of exocrine pancreatic function. A value below 200 µg/g stool is indicative of exocrine pancreatic insufficiency.
- Blood tests: Assessment of pancreatic enzymes (lipase, amylase) and nutrient levels.
- Imaging: Ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) of the abdomen to evaluate pancreatic tissue.
- MRCP (Magnetic Resonance Cholangiopancreatography): Visualization of the pancreatic ducts to detect structural changes.
- Secretin stimulation test: A direct functional test in which pancreatic secretion is measured following administration of secretin.
Treatment
Treatment depends on the underlying cause and the degree of secretory loss:
Pancreatic Enzyme Replacement Therapy
The most important treatment is pancreatic enzyme replacement therapy (PERT). Enteric-coated capsules containing pancreatic enzymes (lipase, amylase, protease) are taken with meals to compensate for the reduced endogenous production. Dosage is adjusted based on the fat content of meals.
Dietary Adjustments
A modified diet with regular, low-fat meals can help reduce symptoms. Fat-soluble vitamins (A, D, E, K) may need to be supplemented.
Treatment of the Underlying Condition
Depending on the cause, further measures may include treatment of chronic pancreatitis, management of autoimmune disease with corticosteroids, or oncological therapy for pancreatic cancer.
Avoidance of Alcohol and Nicotine
In cases of chronic pancreatitis, complete abstinence from alcohol and nicotine is essential, as both substances further damage pancreatic tissue.
References
- Lohr J-M et al. - United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. United European Gastroenterology Journal. 2017;5(2):153-199.
- Dominguez-Munoz JE. - Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Gastroenterology and Hepatology. 2011;7(6):401-403.
- Capurso G et al. - Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clinical and Experimental Gastroenterology. 2019;12:129-139.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMacronutrients
Food craving
Portion control
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Pancreatic Secretory Atrophy-en